Drugmaker Aspen targets Mounjaro approval in sub-Saharan Africa this year
Drugmaker Aspen targets Mounjaro approval in sub-Saharan Africa this year is drawing significant interest across the industry.
Aspen Pharmacare aims to secure sub?Saharan African approval for Eli Lilly's blockbuster weight?loss drug Mounjaro as early as this year, its CEO said on Wednesday, capitalising on soaring regional ?demand for obesity treatments.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Iowa doctor says state board investigation had him ‘blacklisted’
- For India, obesity complicates the nutrition challenge
- Tourism in India has moved from margins of policy to centre of national development: Gajendra Singh Shekhawat
- Hello Bacchon maker watched 'every Physics Wallah reel' for Alakh Pandey biopic
Source: Original →